Clinical trials
Withdrawn Multiple Myeloma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
135 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 3 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 4 |
| 2010 | 3 |
| 2011 | 8 |
| 2012 | 6 |
| 2013 | 3 |
| 2014 | 9 |
| 2015 | 9 |
| 2016 | 6 |
| 2017 | 9 |
| 2018 | 6 |
| 2019 | 7 |
| 2020 | 6 |
| 2021 | 11 |
| 2022 | 7 |
| 2023 | 9 |
| 2024 | 6 |
| 2025 | 4 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 135 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 9 |
| University of Arkansas | 8 |
| M.D. Anderson Cancer Center | 6 |
| Wake Forest University Health Sciences | 4 |
| Dana-Farber Cancer Institute | 3 |
| Mayo Clinic | 3 |
| UNC Lineberger Comprehensive Cancer Center | 3 |
| Washington University School of Medicine | 3 |
| AbbVie | 2 |
| Assistance Publique - Hôpitaux de Paris | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 135 |
| Recurrence | 20 |
| Neoplasms, Plasma Cell | 16 |
| Lymphoma | 13 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 12 |
| Lymphoma, Non-Hodgkin | 12 |
| Burkitt Lymphoma | 11 |
| Leukemia, Myeloid, Acute | 11 |
| Leukemia | 10 |
| Lymphoma, B-Cell, Marginal Zone | 10 |
Trials
Showing 76 to 100 of 135. Each trial links to its page on Pharma Observatory.
35 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.